GGrantIndex
Sort

50,496 grants matching lung cancer

Small molecule probes of MYC stability and function intumorigenesis

$567,361
Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2021 · CA

Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer

$567,348
Ramaswamy Govindan · Washington University · U01 · FY2022 · CA

Succinylation and Malonylation as Novel Protein Modifications in Cancer

$567,328
Hening Lin · Cornell University · R01 · FY2013 · CA

Next Generation Rat Models of ER+ Breast Cancer

$567,317
Yi Li · Baylor College Of Medicine · R01 · FY2024 · CA

A Personalized Digital Outreach Intervention for Lung Cancer Screening

$567,242
David P Miller · Wake Forest University Health Sciences · R01 · FY2021 · CA

RRM1 in the Management of Lung Cancer

$567,240
Gerold Bepler · Wayne State University · R01 · FY2010 · CA

Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer

$567,204
Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2024 · CA

Innate DC Govern TH Polarization through the Novel Regulator AIMp1

$567,195
William Karl Decker · Baylor College Of Medicine · R01 · FY2021 · AI

Research Project

$567,188
Christi A Patten · Mayo Clinic Rochester · U54 · FY2012 · CA

Wearable Nanosensor Array for Real-Time Monitoring of Diesel and Gasoline Exhaust

$567,078
Ashok Mulchandani · University Of California Riverside · U01 · FY2007 · ES

Genetic analysis in early age of onset lung cancer patients

$567,057
Jin Jen · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA

Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer

$567,039
Anant Madabhushi · Emory University · R01 · FY2022 · CA

Regulation of Lymphocyte Proliferation and Replicative Capacity

$566,996
Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens

$566,874
Daniel William Cramer · Brigham And Women'S Hospital · R01 · FY2012 · CA

The Role of Fgf Signaling in Vertebrate Development

$566,741
Mark B Lewandoski · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Stanford Project 2

$566,735
Calvin J Kuo · University Of California, San Francisco · U54 · FY2019 · CA

Lung Adenocarcinoma Invasion Genomics

$566,724
Charles A. Powell · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA

Lung Adenocarcinoma Invasion Genomics

$566,724
Charles A. Powell · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA

Lung Adenocarcinoma Invasion Genomics

$566,724
Charles A. Powell · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · CA

Translating Molecular and Clinical Data to Population Lung Cancer Risk Assessment

$566,670
Rayjean J. Hung · Baylor College Of Medicine · U19 · FY2020 · CA

Interactions between tobacco smoke constituents in rodent tumor models

$566,663
Lisa A Peterson · University Of Minnesota · R01 · FY2018 · CA

Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma

$566,658
David Charles Lyden · Weill Medical Coll Of Cornell Univ · U01 · FY2016 · CA

Evaluating prostate cancer phenotype and genotype classification from circulating tumor DNA as biomarkers for predicting treatment outcomes

$566,644
Gavin Ha · Fred Hutchinson Cancer Center · R01 · FY2024 · CA

Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients

$566,558
Gwen Karilyn Wyatt · Michigan State University · R01 · FY2016 · CA

Molecular features impacting drug resistance in atypical EGFR exon 18 and exon 20 mutant non-small cell lung cancers and the development of novel mutant-selective inhibitors

$566,537
John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA